Literature DB >> 22689580

Simple pseudo-dipeptides with a P2' glutamate: a novel inhibitor family of matrix metalloproteases and other metzincins.

Laurent Devel1, Fabrice Beau, Mehdi Amoura, Laura Vera, Evelyne Cassar-Lajeunesse, Sandra Garcia, Bertrand Czarny, Enrico A Stura, Vincent Dive.   

Abstract

A series of pseudo-peptides with general formula X-l-Glu-NH(2) (with X corresponding to an acyl moiety with a long aryl-alkyl side chain) have been synthesized, evaluated as inhibitors of matrix metalloproteases (MMPs), and found to display remarkable nanomolar affinity. The loss in potency associated with a substitution of the P(2)' l-glutamate by a l-glutamine corroborates the importance of a carboxylate at this position. The binding mode of some of these inhibitors was characterized in solution and by x-ray crystallography in complex with various MMPs. The x-ray crystal structures reveal an unusual binding mode with the glutamate side chain chelating the active site zinc ion. Competition experiments between these inhibitors and acetohydroxamic acid, a small zinc-binding molecule, are in accord with the crystallographic results. One of these pseudo-dipeptides displays potency and selectivity toward MMP-12 similar to the best MMP-12 inhibitors reported to date. This novel family of pseudo peptides opens new opportunities to develop potent and selective inhibitors for several metzincins.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22689580      PMCID: PMC3411004          DOI: 10.1074/jbc.M112.380782

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  Design and therapeutic application of matrix metalloproteinase inhibitors.

Authors:  M Whittaker; C D Floyd; P Brown; A J Gearing
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

Review 2.  Structural basis of matrix metalloproteinase function.

Authors:  Wolfram Bode
Journal:  Biochem Soc Symp       Date:  2003

Review 3.  Matrix metalloproteinases as valid clinical targets.

Authors:  Barbara Fingleton
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

Review 4.  Matrix metalloproteinases: fold and function of their catalytic domains.

Authors:  Cynthia Tallant; Aniebrys Marrero; F Xavier Gomis-Rüth
Journal:  Biochim Biophys Acta       Date:  2009-04-15

5.  Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors.

Authors:  Alexander Heim-Riether; Steven J Taylor; Shuang Liang; Donghong Amy Gao; Zhaoming Xiong; E Michael August; Brandon K Collins; Bennett T Farmer; Kathleen Haverty; Melissa Hill-Drzewi; Hans-Dieter Junker; S Mariana Margarit; Neil Moss; Thomas Neumann; John R Proudfoot; Lana Smith Keenan; Renate Sekul; Qiang Zhang; Jun Li; Neil A Farrow
Journal:  Bioorg Med Chem Lett       Date:  2009-08-03       Impact factor: 2.823

6.  A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models.

Authors:  Vijaykumar M Baragi; Gabriel Becher; Alison M Bendele; Ralf Biesinger; Harald Bluhm; Jürgen Boer; Hongbo Deng; Rory Dodd; Michael Essers; Tim Feuerstein; Brian M Gallagher; Christian Gege; Matthias Hochgürtel; Michael Hofmann; Andreas Jaworski; Lixia Jin; Andrew Kiely; Brian Korniski; Heiko Kroth; Darrell Nix; Bert Nolte; Dorothea Piecha; Timothy S Powers; Frank Richter; Matthias Schneider; Christoph Steeneck; Irving Sucholeiki; Arthur Taveras; Andreas Timmermann; Joshua Van Veldhuizen; Juergen Weik; Xinyuan Wu; Bing Xia
Journal:  Arthritis Rheum       Date:  2009-07

Review 7.  Third generation of matrix metalloprotease inhibitors: Gain in selectivity by targeting the depth of the S1' cavity.

Authors:  Laurent Devel; Bertrand Czarny; Fabrice Beau; Dimitris Georgiadis; Enrico Stura; Vincent Dive
Journal:  Biochimie       Date:  2010-08-07       Impact factor: 4.079

8.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

9.  A selective matrix metalloproteinase-12 inhibitor retards atherosclerotic plaque development in apolipoprotein E-knockout mice.

Authors:  Jason L Johnson; Laurent Devel; Bertrand Czarny; Sarah J George; Christopher L Jackson; Vassilis Rogakos; Fabrice Beau; Athanasios Yiotakis; Andrew C Newby; Vincent Dive
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-01-06       Impact factor: 8.311

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  7 in total

1.  Discovery of a New Class of Potent MMP Inhibitors by Structure-Based Optimization of the Arylsulfonamide Scaffold.

Authors:  Mattia Mori; Assunta Massaro; Vito Calderone; Marco Fragai; Claudio Luchinat; Alessandro Mordini
Journal:  ACS Med Chem Lett       Date:  2013-05-14       Impact factor: 4.345

2.  Synthesis and in Vitro and in Vivo Evaluation of MMP-12 Selective Optical Probes.

Authors:  Thomas Bordenave; Marion Helle; Fabrice Beau; Dimitris Georgiadis; Livia Tepshi; Mylène Bernes; Yunpeng Ye; Laure Levenez; Enora Poquet; Hervé Nozach; Mahmoud Razavian; Jakub Toczek; Enrico A Stura; Vincent Dive; Mehran M Sadeghi; Laurent Devel
Journal:  Bioconjug Chem       Date:  2016-09-14       Impact factor: 4.774

Review 3.  Matrix metalloproteinases as breast cancer drivers and therapeutic targets.

Authors:  Evette S Radisky; Derek C Radisky
Journal:  Front Biosci (Landmark Ed)       Date:  2015-06-01

Review 4.  Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Inflammation and Fibrosis of Skeletal Muscles.

Authors:  Hala S Alameddine; Jennifer E Morgan
Journal:  J Neuromuscul Dis       Date:  2016-11-29

Review 5.  Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer.

Authors:  Evette S Radisky; Maryam Raeeszadeh-Sarmazdeh; Derek C Radisky
Journal:  J Cell Biochem       Date:  2017-07-17       Impact factor: 4.429

Review 6.  Regulation and involvement of matrix metalloproteinases in vascular diseases.

Authors:  Matthew Amin; Sathnur Pushpakumar; Nino Muradashvili; Sourav Kundu; Suresh C Tyagi; Utpal Sen
Journal:  Front Biosci (Landmark Ed)       Date:  2016-01-01

Review 7.  Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics.

Authors:  Maryam Raeeszadeh-Sarmazdeh; Linh D Do; Brianne G Hritz
Journal:  Cells       Date:  2020-05-25       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.